GTXI Gtx, Inc.

GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, and other senior executive management team members will present a company overview at the Baird 2018 Global Healthcare Conference on Thursday, September 6, 2018 at 9:05 am ET in New York.

A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.

About GTx

GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious and/or significant unmet medical conditions, including stress urinary incontinence and prostate cancer.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180830005108/en/

GTx, Inc.Investors:Argot PartnersKimberly Minarovich or Sam Martin212-600-1902orMedia:Red House ConsultingDenise Powell, 510-703-9491denise@redhousecomms.com

Gtx, Inc. (NASDAQ:GTXI)
Historical Stock Chart
From Dec 2024 to Jan 2025

Gtx, Inc. (NASDAQ:GTXI)
Historical Stock Chart
From Jan 2024 to Jan 2025